Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition

Cell Research

Volumn 23, Issue 11, 2013, Pages 1256-1269

  Maunakea, Alika K ^a,b   Chepelev, Iouri ^a,c   Cui, Kairong ^a   Zhao, Keji ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b UNIVERSITY OF HAWAII   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

chromatin; epigenomics; histone acetylation; intragenic DNA methylation; MeCP2; splicing

Indexed keywords

MECP2 PROTEIN, HUMAN; METHYL CPG BINDING PROTEIN 2;

ALTERNATIVE RNA SPLICING; CELL LINE; DNA METHYLATION; EXON; GENETICS; HCT116 CELL LINE; HUMAN; METABOLISM;

ALTERNATIVE SPLICING; CELL LINE; DNA METHYLATION; EXONS; HCT116 CELLS; HUMANS; METHYL-CPG-BINDING PROTEIN 2;

EID: 84887214395     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2013.110     Document Type: Article

References (46)

1. Chen ZX, Riggs AD. DNA methylation and demethylation in mammals. J Biol Chem 2011; 286:18347-18353.
2. Jones PA, Takai D. The role of DNA methylation in mammalian epigenetics. Science 2001; 293:1068-1070. (Pubitemid 32758075)
3. Klose RJ, Bird AP. Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci 2006; 31:89-97. (Pubitemid 43221841)
4. Deaton AM, Webb S, Kerr AR, et al. Cell type-specifc DNA methylation at intragenic CpG islands in the immune system. Genome Res 2011; 21:1074-1086.
5. Illingworth R, Kerr A, Desousa D, et al. A novel CpG island set identifes tissue-specifc methylation at developmental gene loci. PLoS Biol 2008; 6:e22.
6. Liang P, Song F, Ghosh S, et al. Genome-wide survey reveals dynamic widespread tissue-specifc changes in DNA methyla-tion during development. BMC Genomics 2011; 12:231.
7. Maunakea AK, Nagarajan RP, Bilenky M, et al. Conserved role of intragenic DNA methylation in regulating alternative promoters. Nature 2010; 466:253-257.
8. Anastasiadou C, Malousi A, Maglaveras N, Kouidou S. Human epigenome data reveal increased CpG methylation in alternatively spliced sites and putative exonic splicing enhancers. DNA Cell Biol 2011; 30:267-275.
9. Chodavarapu RK, Feng S, Bernatavichute YV, et al. Relationship between nucleosome positioning and DNA methylation. Nature 2010; 466:388-392.
10. Choi JK. Contrasting chromatin organization of CpG islands and exons in the human genome. Genome Biol 2010; 11:R70.
11. Feng S, Cokus SJ, Zhang X, et al. Conservation and divergence of methylation patterning in plants and animals. Proc Natl Acad Sci USA 2010; 107:8689-8694.
12. Shukla S, Kavak E, Gregory M, et al. CTCF-promoted RNA polymerase II pausing links DNA methylation to splicing. Nature 2011; 479:74-79.
13. Luco RF, Allo M, Schor IE, Kornblihtt AR, Misteli T. Epi-genetics in alternative pre-mRNA splicing. Cell 2011; 144:16-26.
14. Lorincz MC, Dickerson DR, Schmitt M, Groudine M. Intra-genic DNA methylation alters chromatin structure and elongation effciency in mammalian cells. Nat Struct Mol Biol 2004; 11:1068-1075. (Pubitemid 39453335)
15. Lister R, Pelizzola M, Dowen RH, et al. Human DNA methy-lomes at base resolution show widespread epigenomic differences. Nature 2009; 462:315-322.
16. Mossman D, Kim KT, Scott RJ. Demethylation by 5-aza-2′- deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists. BMC Cancer 2010; 10:366.
17. Rhee I, Bachman KE, Park BH, et al. DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature 2002; 416:552-556. (Pubitemid 34288859)
18. Wozniak RJ, Klimecki WT, Lau SS, Feinstein Y, Futscher BW. 5-Aza-2′-deoxycytidine-mediated reductions in G9A histone methyltransferase and histone H3 K9 di-methylation levels are linked to tumor suppressor gene reactivation. Oncogene 2007; 26:77-90. (Pubitemid 46067333)
19. Schor IE, Rascovan N, Pelisch F, Allo M, Kornblihtt AR. Neu-ronal cell depolarization induces intragenic chromatin modif-cations affecting NCAM alternative splicing. Proc Natl Acad Sci USA 2009; 106:4325-4330.
20. Nan X, Meehan RR, Bird A. Dissection of the methyl-CpG binding domain from the chromosomal protein MeCP2. Nucleic Acids Res 1993; 21:4886-4892. (Pubitemid 23330162)
21. Long SW, Ooi JY, Yau PM, Jones PL. A brain-derived MeCP2 complex supports a role for MeCP2 in RNA processing. Biosci Rep 2011; 31:333-343.
22. Young JI, Hong EP, Castle JC, et al. Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2. Proc Natl Acad Sci USA 2005; 102:17551-17558. (Pubitemid 41803535)
23. Yasui DH, Peddada S, Bieda MC, et al. Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes. Proc Natl Acad Sci USA 2007; 104:19416-19421.
24. Nan X, Ng HH, Johnson CA, et al. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 1998; 393:386-389. (Pubitemid 28269714)
25. Ip JY, Schmidt D, Pan Q, et al. Global impact of RNA poly-merase II elongation inhibition on alternative splicing regulation. Genome Res 2011; 21:390-401.
26. Allo M, Schor IE, Munoz MJ, et al. Chromatin and alternative splicing. Cold Spring Harb Symp Quant Biol 2010; 75:103-111.
27. Zhou HL, Hinman MN, Barron VA, et al. Hu proteins regulate alternative splicing by inducing localized histone hyperacety-lation in an RNA-dependent manner. Proc Natl Acad Sci USA 2011; 108:E627-635.
28. Wood AJ, Schulz R, Woodfne K, et al. Regulation of alternative polyadenylation by genomic imprinting. Genes Dev 2008; 22:1141-1146. (Pubitemid 351656573)
29. de la Mata M, Alonso CR, Kadener S, et al. A slow RNA poly-merase II affects alternative splicing in vivo. Mol Cell 2003; 12:525-532. (Pubitemid 37238937)
30. Core LJ, Waterfall JJ, Lis JT. Nascent RNA sequencing reveals widespread pausing and divergent initiation at human promoters. Science 2008; 322:1845-1848.
31. Tilgner H, Nikolaou C, Althammer S, et al. Nucleosome positioning as a determinant of exon recognition. Nat Struct Mol Biol 2009; 16:996-1001.
32. Kelly TK, Liu Y, Lay FD, Liang G, Berman BP, Jones PA. Genome-wide mapping of nucleosome positioning and DNA methylation within individual DNA molecules. Genome Res 2012; 22:2497-2506.
33. Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 1999; 23:185-188. (Pubitemid 29455390)
34. LaSalle JM, Hogart A, Thatcher KN. Rett syndrome: a Rosetta stone for understanding the molecular pathogenesis of autism. Int Rev Neurobiol 2005; 71:131-165. (Pubitemid 43580937)
35. Moretti P, Zoghbi HY. MeCP2 dysfunction in Rett syndrome and related disorders. Curr Opin Genet Dev 2006; 16:276-281. (Pubitemid 43732423)
36. Webb R, Wren JD, Jeffries M, et al. Variants within MECP2, a key transcription regulator, are associated with increased susceptibility to lupus and differential gene expression in patients with systemic lupus erythematosus. Arthritis Rheum 2009; 60:1076-1084.
37. Nagarajan RP, Hogart AR, Gwye Y, Martin MR, LaSalle JM. Reduced MeCP2 expression is frequent in autism frontal cortex and correlates with aberrant MECP2 promoter methylation. Epigenetics 2006; 1:e1-e11.
38. Nagarajan RP, Patzel KA, Martin M, et al. MECP2 promoter methylation and X chromosome inactivation in autism. Autism Res 2008; 1:169-178.
39. Lei W, Luo Y, Lei W, et al. Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythemato-sus, systemic sclerosis, and dermatomyositis. Scand J Rheu-matol 2009; 38:369-374.
40. Tazi J, Bakkour N, Stamm S. Alternative splicing and disease. Biochim Biophys Acta 2009; 1792:14-26.
41. Barski A, Cuddapah S, Cui K, et al. High-resolution profiling of histone methylations in the human genome. Cell 2007; 129:823-837. (Pubitemid 46802390)
42. Wan M, Zhao K, Lee SS, Francke U. MECP2 truncating mutations cause histone H4 hyperacetylation in Rett syndrome. Hum Mol Genet 2001; 10:1085-1092. (Pubitemid 32447786)
43. Trapnell C, Pachter L, Salzberg SL. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 2009; 25:1105-1111.
44. Kharchenko PV, Tolstorukov MY, Park PJ. Design and analysis of ChIP-seq experiments for DNA-binding proteins. Nat Biotechnol 2008; 26:1351-1359.
45. Zhang Y, Liu T, Meyer CA, et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol 2008; 9:R137.
46. Hahn MA, Wu X, Li AX, Hahn T, Pfeifer GP. Relationship between gene body DNA methylation and intragenic H3K9me3 and H3K36me3 chromatin marks. PLoS One 2011; 6:e18844.